![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DJ Waxman, PA Ram, NA Pampori and BH Shapiro
Department of Biology, Boston University, Massachusetts 02215, USA.
Growth hormone (GH) secretory patterns regulate the expression of several sex-dependent liver cytochrome P450 (CYP) genes. Studies using the hypophysectomized rat model have established that the intermittent plasma GH secretory pattern associated with adult male rats markedly stimulates liver expression of the male-specific CYP 2C11, a testosterone 2 alpha- and 16 alpha-hydroxylase, but is not required for expression of other male-specific liver enzymes, including CYP 2A2, a testosterone 15 alpha-hydroxylase, and CYP 3A2, a testosterone 6 beta- hydroxylase. In the present study, the effects of intermittent GH treatment on liver CYP expression were studied in adult rats rendered GH deficient by neonatal administration of monosodium glutamate (MSG), which depletes circulating adult GH without the global loss of other pituitary-dependent hormones that is associated with hypophysectomy. Restoration of the normal masculine circulating GH profile of six daily pulses (180-225 ng GH/ml/peak) in MSG-treated male rats by the use of an external pumping apparatus led to a substantial (30-50%) restoration of normal male levels of CYP 2A2 and CYP 3A2 activity, protein, and mRNA. GH pulsation at the nonphysiological frequencies of two or four times per day was less effective unless given at a dose that resulted in supraphysiological plasma GH levels. Although intermittent GH treatment can induce male-specific P450 expression in hypophysectomized female rats, the same hormone treatment did not stimulate CYP 2A2 or CYP 3A2 expression in MSG-treated female rats. Liver GH receptor mRNA levels at adulthood were not significantly altered by neonatal MSG treatment, suggesting that the unresponsiveness of MSG-treated females and the previously reported low responsiveness of MSG-treated males to GH-induced CYP 2C11 expression are not due to the absence of GH receptor. Moreover, normal liver IGF-1 mRNA levels were expressed in the MSG-treated female rats, suggesting that the liver GH receptor is functional in these animals. The present findings establish that the adult male-specific enzymes CYP 2A2 and CYP 3A2 can be positively regulated by intermittent GH pulsation despite their GH-independent expression in hypophysectomized rats. Moreover, neonatal MSG treatment, particularly in female rats, may lead to the loss of factors other than GH that are required for full expression of the pulsatile GH-stimulated CYP 2A2, 3A2, and 2C11 genes.
This article has been cited by other articles:
|
|
 |
|
  C. Thangavel and B. H. Shapiro Inherent Sexually Dimorphic Expression of Hepatic CYP2C12 Correlated with Repressed Activation of Growth Hormone-Regulated Signal Transduction in Male Rats Drug Metab. Dispos., September 1, 2008; 36(9): 1884 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Wauthier and D. J. Waxman Sex-Specific Early Growth Hormone Response Genes in Rat Liver Mol. Endocrinol., August 1, 2008; 22(8): 1962 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. de Kloet and R. A. Sarabdjitsingh Everything Has Rhythm: Focus on Glucocorticoid Pulsatility Endocrinology, July 1, 2008; 149(7): 3241 - 3243. [Full Text] [PDF]
|
|
|
|
|
|
R. N. Dhir, C. Thangavel, and B. H. Shapiro Attenuated Expression of Episodic Growth Hormone-Induced CYP2C11 in Female Rats Associated with Suboptimal Activation of the Jak2/Stat5B and Other Modulating Signaling Pathways Drug Metab. Dispos., November 1, 2007; 35(11): 2102 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Conway-Campbell, M. A. McKenna, C. C. Wiles, H. C. Atkinson, E. R. de Kloet, and S. L. Lightman Proteasome-Dependent Down-Regulation of Activated Nuclear Hippocampal Glucocorticoid Receptors Determines Dynamic Responses to Corticosterone Endocrinology, November 1, 2007; 148(11): 5470 - 5477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Anakk, W. Huang, J. L. Staudinger, K. Tan, T. J. Cole, D. D. Moore, and H. W. Strobel Gender Dictates the Nuclear Receptor-Mediated Regulation of CYP3A44 Drug Metab. Dispos., January 1, 2007; 35(1): 36 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Thangavel, W. Dworakowski, and B. H. Shapiro INDUCIBILITY OF MALE-SPECIFIC ISOFORMS OF CYTOCHROME P450 BY SEX-DEPENDENT GROWTH HORMONE PROFILES IN HEPATOCYTE CULTURES FROM MALE BUT NOT FEMALE RATS Drug Metab. Dispos., March 1, 2006; 34(3): 410 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths, and L. H. Patterson A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY Drug Metab. Dispos., April 1, 2004; 32(4): 382 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Krebs, L. K. Larkins, R. Price, K. M. Tullis, R. D. Miller, and D. M. Robins Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression Genes & Dev., November 1, 2003; 17(21): 2664 - 2674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wadsworth, H. Poonyagariyagorn, E. Sullivan, D. Koop, and C. E. Roselli In Vivo Effect of PC-SPES on Prostate Growth and Hepatic CYP3A Expression in Rats J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 187 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Anakk, C. Y. Ku, M. Vore, and H. W. Strobel Insights into Gender Bias: Rat Cytochrome P450 3A9 J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 703 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Lu, S. M. Callahan, and L. J. Brunner Suppression of Hepatic CYP3A1/2 and CYP2C11 by Cyclosporine Is Not Mediated by Altering Growth Hormone Levels J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 331 - 337. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. A. Jaffe, D. K. Turgeon, K. Lown, R. Demott-Friberg, and P. B. Watkins Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1008 - E1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kalsotra, S. Anakk, C. L. Boehme, and H. W. Strobel Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats Drug Metab. Dispos., September 1, 2002; 30(9): 1022 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ji, S. J. Frank, and J. L. Messina Growth Hormone-induced Differential Desensitization of STAT5, ERK, and Akt Phosphorylation J. Biol. Chem., August 9, 2002; 277(32): 28384 - 28393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaufhold, P. K. Nigam, R. N. Dhir, and B. H. Shapiro Prevention of Latently Expressed CYP2C11, CYP3A2, and Growth Hormone Defects in Neonatally Monosodium Glutamate-Treated Male Rats by the N-Methyl-D-Aspartate Receptor Antagonist Dizocilpine Maleate J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 490 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Frost, G. J. Nystrom, and C. H. Lang Regulation of IGF-I mRNA and Signal Transducers and Activators of Transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 Myoblasts Endocrinology, February 1, 2002; 143(2): 492 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Agrawal and B. H. Shapiro Differential Expression of Gender-Dependent Hepatic Isoforms of Cytochrome P-450 by Pulse Signals in the Circulating Masculine Episodic Growth Hormone Profile of the Rat J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 228 - 237. [Abstract] [Full Text]
|
|
|
|
|
|
N. A. Pampori and B. H. Shapiro Gender Differences in the Responsiveness of the Sex-Dependent Isoforms of Hepatic P450 to the Feminine Plasma Growth Hormone Profile Endocrinology, March 1, 1999; 140(3): 1245 - 1254. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]
|
|
|
|
|
|
A. K. Agrawal and B. H. Shapiro Gender, Age and Dose Effects of Neonatally Administered Aspartate on the Sexually Dimorphic Plasma Growth Hormone Profiles Regulating Expression of the Rat Sex-Dependent Hepatic CYP Isoforms Drug Metab. Dispos., November 1, 1997; 25(11): 1249 - 1256. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
